/Zoetis%20Inc%20HQ%20sign-by%20JHVEPhoto%20via%20Shutterstock.jpg)
Parsippany, New Jersey-based Zoetis Inc. (ZTS) discovers, develops, and commercializes animal health medicines, vaccines, and diagnostic products and services. With a market cap of $79.9 billion, Zoetis’ operations span over 100 countries in North America, Europe, and internationally.
The animal health giant has significantly underperformed the broader market over the past year. ZTS stock has declined 10.3% on a YTD basis and gained 4.9% over the past 52 weeks lagging behind the S&P 500 Index’s ($SPX) rally of 25.5% in 2024 and 35.7% over the past 52-week period.